Skip to main content
. 2018 Sep 25;109(11):3554–3563. doi: 10.1111/cas.13772

Table 4.

Details of surgery in Japanese patients with resectable esophageal squamous cell carcinoma treated with docetaxel, nedaplatin, and 5‐fluorouracil

n %
Surgical approach
Thoracoscopic surgery 20 80.0
Right thoracotomy 5 20.0
Residual tumora
R0 25 100
R1/R2 0 0.0
Postoperative 30‐d mortality 0 0.0
Pathological tumor responseb
0 2 8.0
1a 5 20.0
1b 2 8.0
2 8 32.0
3 8 32.0
Post‐therapy T stagea
ypT0 8 32.0
ypT1 8 32.0
ypT2 2 8.0
ypT3 6 24.0
ypT4 1 4.0
Post‐therapy N stagea
ypN0 15 60.0
ypN1 7 28.0
ypN2 2 8.0
ypN3 1 4.0
Post‐therapy ypStagea
ypStage 0 6 24.0
ypStage IA 5 20.0
ypStage IB 0 0.0
ypStage IIA 4 16.0
ypStage IIB 6 24.0
ypStage IIIA 0 0.0
ypStage IIIB 2 8.0
ypStage IIIC 2 8.0
Surgical complication
Recurrent laryngeal nerve palsy 4 16.0
Anastomotic leakage 1 4.0
Chylothorax 1 4.0
Gastrointestinal anastomotic stenosis 4 16.0
Wound infection 2 8.0
Pneumonia 1 4.0
Subcutaneous emphysema 1 4.0
a

According to the UICC TNM system (7th edition).

b

According to the Japanese Classification of Esophageal Cancer (10th edition).